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Ataxin-7 (Atx7) is a component of the nuclear transcription co-activator complex; its polyglutamine
(polyQ) expansion may cause nuclear accumulation and recruit numerous proteins to the intranu-
clear inclusion bodies. Full-length R85 (R85FL) is such a protein sequestered by polyQ-expanded
Atx7. Here, we report that Atx7 speciﬁcally interacts with the third SH3 domain (SH3C) of R85FL
through its second portion of proline-rich region (PRR). NMR structural analysis of the SH3C domain
and its complex with PRR revealed that SH3C contains a large negatively charged surface for binding
with the RRTR motif of Atx7. Microscopy imaging demonstrated that sequestration of R85FL by the
polyQ-expanded Atx7 in cell is mediated by this speciﬁc SH3C–PRR interaction, which is implicated
in the pathogenesis of spinocerebellar ataxia 7.
Structured summary of protein interactions:
Atx7 PP2 and SH3C bind by isothermal titration calorimetry (View
Interaction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
Atx7 binds to SH3C by pull down (View interaction)
Atx7100Q and SH3C colocalize by ﬂuorescence microscopy (View interaction)
SH3C and Atx7 bind by nuclear magnetic resonance (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction There are nine inherited neurodegenerative disorders relatedSpinocerebellar ataxia 7 (SCA7) is an autosomal dominant neu-
rodegenerative disorder characterized by cerebellar ataxia associ-
ated with progressive macular dystrophy [1,2]. SCA7 is generally
considered to be caused by expansion of a CAG repeat encoding
polyglutamine (polyQ) tract in the protein ataxin-7 (Atx7) [3].
Atx7 is a component of mammalian STAGA (SPT3-TAF9-ADA-
GCN5 acetyltransferase) transcription co-activator complex, and
its polyQ expansion inhibits STAGA histone acetyltransferase activ-
ity [4,5]. Moreover, its yeast form regulates ubiquitin levels of his-
tone H2B and links histone deubiquitination with gene gating and
mRNA export [6]. Thus, impairments of these normal functions by
polyQ expansion of Atx7 may underlie the production of SCA7
phenotype.to polyQ expansion, the hallmark of this kind of disease is the
formation of nuclear inclusion bodies [7]. The intranuclear inclu-
sions found in human SCA7 brain contain many other proteins,
including transcriptional regulators, ubiquitin/proteasome path-
way components, cell death associated proteins, and chaperones
and their partners [1]. The function of all these proteins can pos-
sibly be inﬂuenced by polyQ expansion of Atx7. However,
whether these proteins are recruited to inclusions by polyQ ex-
panded Atx7 through speciﬁc or non-speciﬁc protein interactions
remains largely unknown. One such protein sequestered by pol-
yQ expanded Atx7 to intranuclear inclusions is full-length R85
(R85FL), a splice variant of ponsin or Cbl-associated protein
(CAP). R85FL/ponsin belongs to the SoHo adaptor protein family
that regulates cytoskeletal organization and signal transduction
[8]. There are three members of this family; all contain three
highly conserved Src homology 3 (SH3) domains in the C-termini.
As known, SH3 domain speciﬁcally recognizes proteins with
proline-rich region (PRR) [9–11]. The canonical binding sites for
SH3 domains usually include the amino-acid sequences like R/
KxxPxxP (class I) or PxxPxR/K (class II) [10,12]. Like huntingtin
(Htt), Atx7 contains a PRR just downstream of the polyQ tract
[13].
2906 Y.-J. Jiang et al. / FEBS Letters 587 (2013) 2905–2911We herein report identiﬁcation and structural analysis for the
interaction of Atx7 PRR with the third SH3 domain (SH3C) of
R85FL. Moreover, R85FL can be sequestered to the nuclear inclu-
sion bodies by polyQ expanded Atx7 through speciﬁc SH3C–PRR
interactions.
2. Materials and methods
2.1. Cloning, expression, peptide synthesis, and protein puriﬁcation
The R85FL gene was cloned from human brain cDNA library
(Invitrogen), and inserted into pcDNA3.0 vector with a FLAG tag
in N-terminus of the protein. The Atx7 gene with 10 or 100 gluta-
mine repeats in the vector pEGFPN1 was a gift from Dr. A. Brice.
The SH3 domains and their mutants were subcloned into pGBTNH
[14] and pGEX-4T-3. The peptides were obtained from solid-phase
chemical synthesis and analyzed by electrospray mass spectrome-
try. The plasmids were transformed into Escherichia coli BL21 (DE3)
cells to overexpress proteins. The proteins were puriﬁed by Ni2+–
NTA or GST afﬁnity column, followed by gel ﬁltration chromatog-
raphy. 15N/13C-labeled proteins were prepared using the M9 mini-
mal medium containing 15NH4Cl and/or 13C6-D-glucose as the sole
nitrogen and/or carbon resource, respectively.
2.2. GST pull-down experiments
The GST-peptide fusions were added to the glutathione Sephar-
ose 4B beads (Amersham Biosciences) in a PBS buffer (140 mM so-
dium chloride, 2.7 mM potassium chloride, 10 mM sodium
phosphate, 1.8 mM potassium phosphate, pH 7.3), and the suspen-
sions were agitated at 4 C for 30 min. The beads were washed
three times with the same buffer to remove any unbound proteins.
An equivalent amount of different SH3 domains were added and
incubated at 4 C for an additional 4 h. Finally, the beads were
recovered by centrifugation, and then the samples were resus-
pended in the sample buffer and subjected to SDS–PAGE (15%
gel), followed by Coomassie staining.
2.3. NMR spectroscopy and structure determination
The sample containing 15N/13C-labeled SH3C protein (1.0 mM)
with or without Atx7_PP2 peptide (4 mM) in a phosphate buffer
(20 mM NaH2PO4, 50 mM NaCl, pH6.5) was used for the structural
determination by NMR. All data were acquired at 25 C on a Bruker
Avance 600-MHz spectrometer. The spectra including HNCO,
HNCACB, CBCA(CO)NH, H(CCO)NH, C(CO)NH and HCCH-TOCSY
were obtained for the backbone and side-chain assignments. NOE
restraints were obtained from 15N- and 13C-edited NOESY spectra
with a mixing time of 100 ms. The NMR data were processed using
NMRPipe and analyzed with SPARKY. Backbone dihedral restraints
were derived from TALOS program. The structures were calculated
using ARIA2.0, assessed with PROCHECK, and displayed with
MOLMOL.
2.4. MTSL labeling and paramagnetic relaxation enhancement (PRE)
A Cys residue was introduced to the N- or C-terminus of
Atx7_PP2, and the peptide fused with GB1 was obtained with
pGBTNH expression vector [14]. After puriﬁcation, MTSL ((1-oxyl-
2,2,5,5-tetramethyl pyrroline-3-methyl) methanethiosulfonate)
(ALEXIS Biochemicals, San Diego) was incubated with Atx7_PP2 at
4 C overnight. Ten-fold excess of MTSL was used for the reaction
and the excess MTSL was removed by desalting [11]. In the PRE
experiment, after collecting a HSQC spectrum, dithiothreitol (DTT,
10 mM) was added to the mixture in the NMR tube and stayed atroom temperature for 5 h to remove MTSL from the Atx7_PP2 pep-
tide, and then another HSQC spectrum was acquired for reference
[15]. The peak intensities with and without MTSL in the HSQC spec-
tra of SH3C were compared for identifying the residues that are
close to the N- or C-terminus of the peptide.
2.5. Construction of the complex structure
The complex structure was generated by HADDOCK2.1 [16]. The
structures of SH3C in the peptide-bound form solved by NMR and
Atx7-PP2 generated by homology modeling from the known pro-
line-rich peptide (PDB ID: 2DF6) were used as initials for docking.
The residues that have chemical-shift changes larger than the
average value were treated as signiﬁcantly perturbed residues.
The active residues included Y13, Y15, N19, D21, D39, W41, P56
and Y59 of SH3C, and all residues of Atx7-PP2. The PRE-derived
intermolecular distances were introduced as unambiguous re-
straints. Only those residues with resonance peaks signiﬁcantly
broadened or almost disappeared by paramagnetic effect were
used as inputs for structure calculation. Normally the distance be-
tween the amide nitrogen atoms of SH3C and the paramagnetic
oxygen of MTSL was set as 10 ± 3 Å. The ambiguous constraints
were further modiﬁed by the fact that Pro56 of SH3C has intermo-
lecular NOEs with the prolines of Atx7_PP2. The docking protocol
included three stages with a ﬁnal explicit water reﬁnement. At
the last iteration, 200 structures were generated and clustered by
an RMSD cut-off of 3 Å.
2.6. Isothermal titration calorimetry (ITC)
ITC was performed with an ITC200 MicroCalorimeter (Micro-
Cal). Proteins were dissolved at 100 lM in a PBS buffer (140 mM
sodium chloride, 2.7 mM potassium chloride, 10 mM sodium phos-
phate, 1.8 mM potassium phosphate, pH 7.3; or 20 mM sodium
phosphate, 50 mM sodium chloride, pH 6.5 or 7.0). Upon reaching
the equilibrium temperature of 25 C, different peptides were ti-
trated from a syringe into a sample chamber holding by 20 injec-
tions. Data were obtained using v2 minimization on a model
assuming a single set of sites to calculate the binding afﬁnity.
2.7. Cell culture and immunoﬂuorescence microscopy
HEK 293T cells were transfected by FuGENE HD transfection
reagent (Roche) following the manufacturer’s instructions. Anti-
FLAG antibody (Sigma) was used for immuno-ﬂuorescence. For
confocal microscopy, HEK 293T cells were grown on glass cover-
slips for 48 h after transfection. Images were obtained on a Leica
TCS SP2 confocal microscope (Leica Microsystems).
3. Results
3.1. Atx7 PRR speciﬁcally interacts with the third SH3 domain of R85FL
By using two-hybrid approach to screen human retina cDNA li-
brary, a protein named R85 was identiﬁed for binding with Atx7
[13]. In addition, the R85FL was also found to co-localize with
Atx7 [13]. R85FL is a splice variant of the SH3P12 gene product.
All variants have three repeated SH3 domains located at the C-ter-
mini (Fig. 1A). As known, SH3 is a modular domain recognizing
proline-rich motifs [9,11], while Atx7 contains a PRR motif located
at the N-terminus just behind the polyQ tract (Fig. 1A). To get
molecular details of the recognition between Atx7 and R85FL, we
examined the interactions of Atx7 PRR with different SH3 domains
of R85FL by GST pull-down analysis. The results show that Atx7
PRR can interact with the third SH3 domain (as referred to SH3C)
Fig. 1. Atx7 PRR speciﬁcally interacts with the third SH3 domain of R85FL. (A)
Schematic representation of Atx7, R85FL and the PRR peptide portions of Atx7.
PP12, the PRR sequence of Atx7; PP1, the ﬁrst portion; PP2, the second portion. (B)
GST pull-down experiment for testing the interaction of GST-PP12 with SH3A. (C)
As in (B), GST-PP12 with SH3B. (D) As in (B), GSP-PP12 with SH3C. (E) GST pull-
down experiment for testing the interaction between GST-PP1 or GST-PP2 and
SH3C. The GST pull-down experiments were detected by Coomassie blue staining.
The extra bands in the gels are due to degradation of GST or GST fused proteins.
Fig. 2. Solution structures of SH3C in free and peptide-bound states. (A) Sequence alignm
while the negatively charged residues in SH3C that are not present in SH3A or SH3B are
distal loop are indicated at the top of the sequence. (B) A cluster of 15 best structures
Atx7_PP2 bound state (PDB ID: 2LJ1). (D) Comparison of the average structures of SH3C in
SH3 domains from R85FL. The positive and negative charges are shown in blue and red, r
SH3B (2O9S) and SH3C (2LJ0).
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nor the second (SH3B) (Fig. 1C). SH3 domain canonically binds
with such amino-acid sequence as R/KxxPxxP (class I) or PxxPxR/
K (class II) [10,12]. So we dissected the Atx7 PRR sequence into
two parts, namely Atx7_PP1 and Atx7_PP2 (Fig. 1A), each contain-
ing a class-II consensus peptide motif. Intriguingly, SH3C only
interacts with Atx7_PP2 but not with Atx7_PP1 (Fig. 1E). ITC exper-
iments indicate that Atx7_PP2 has almost the same afﬁnity
(KD = 68 lM) to SH3C when compared with the full-length Atx7
PRR sequence (Atx7_PP12) (Fig. S1), suggesting that the PP2 motif
in Atx7 is the major binding moiety for SH3C. NMR titration further
corroborates our observation from GST pull-down experiments
(Fig. S2). The dissociation constant (KD) for SH3C binding with
Atx7_PP2 is around a range of 50 lM. However, SH3A is incapable
of binding with Atx7_PP1 or Atx7_PP2. Altogether, these results
demonstrate that the PP2 motif of Atx7 speciﬁcally interacts with
the third SH3 domain of R85FL.
3.2. Solution structures of SH3C in free and peptide-bound states
The SoHo family adaptor proteins include threemembers, vinex-
in, Arg-binding protein 2 (ArgBP2) and R85FL (ponsin or CAP). Each
protein has one SoHo domain in N-terminus and three SH3 domains
in C-terminus. The SH3 domain is highly conserved among the fam-
ily members with an identity up to 60% (Fig. S3), whereas only 17%
identity among the three SH3 domains of R85FL (Fig. 2A). The struc-
tures of SH3A (2DL3) and SH3B (2O9S) are available in the Protein
Data Bank. By using heteronuclear NMR approach, we solved the
solution structures of the SH3C domain of R85FL in free and PP2-
bound states. The best 15 ﬁnal structures, as judged from energetic
and geometrical considerations, have a backbone RMSD of
0.44 ± 0.08 Å for SH3C alone or 0.61 ± 0.14 Å for it binding withent of the three SH3 domains from R85FL. The conserved residues are in blue box,
indicated with arrows. Positions of the b-strands, 310 helix, RT loop, N-Src loop and
of SH3C in free state (PDB ID: 2LJ0). (C) A cluster of 15 best structures of SH3C in
free (blue) and peptide bound (green) states. (E) Surface representation for the three
espectively, while the hydrophobic regions are shown in gray. PDB ID: SH3A (2DL3),
Fig. 3. Interaction between Atx7_PP2 and SH3C of R85FL. (A) The binding afﬁnity of SH3C with Atx7_PP2 is dependent on the salt concentration in solution. The dissociation
constant (KD) values were obtained from ITC experiments in pH 6.5 or pH 7.0. (B) Chemical-shift perturbation of SH3C upon addition of Atx7_PP2 at the PP2/SH3C ratio of 6:1.
The chemical-shift change was calculated by a combination of hydrogen and nitrogen ðDdav ¼ SQRTðDd2H þ Dd2N=25ÞÞ. The residues with chemical-shift changes larger than
the average (mean) were treated as signiﬁcantly perturbed residues, including Y15, Q18, N19, D20, D21, I30, V31, W41, V43, T54, F55 and Y59. (C) Intermolecular NOEs
between Atx7_PP2 and SH3C. The three columns represent 13C-edited NOE signals for the side-chain of Pro56 in SH3C (left), 13C-edited NOEs for Pro56 saturated with
Atx7_PP2 (middle), and the 13C-ﬁltered/edited intermolecular NOEs for Pro56 with Atx7_PP2 (right). The arrows indicate the intermolecular NOEs for Pro56 of SH3C with
prolines of Atx7_PP2. (D) Ratios of the peak intensities in the HSQC spectra with or without titration of N-terminally MTSL-labeled Atx7_PP2. The region of residues with
strong paramagnetic effect is indicated by an arrow. (E) As in (D), with C-terminally labeled Atx7_PP2 peptide.
Table 1
Binding afﬁnities (KD) of SH3C or its mutants with Atx7_PP2 peptide or its mutants as determined by isothermal titration calorimetry.
Atx7 PRR Peptide PP12 PP2 PP2-R6A PP2-R7A PP2-T8A PP2-R9A
R85L_SH3C
KD (lM) 46.5 ± 7.1 68.0 ± 4.6 980 ± 19 253 ± 45 862 ± 44 588 ± 96
Atx7_PP2
SH3C Mutant Y13A D20A D21A D39A T54A Y59A
KD (lM) >1000 139 ± 24 >1000 571 ± 41 78.1 ± 10.9 >1000
2908 Y.-J. Jiang et al. / FEBS Letters 587 (2013) 2905–2911the PP2 peptide (Table S1). Both structures of the free and PP2-
bound forms display a b-barrel fold of ﬁve b-strands and a 310 helix
(Fig. 2B and C), showing a typical SH3 domain architecture. In com-
parison of the two average structures in free and PP2-bound states,
it appears that binding of the PP2 peptide does not cause any signif-
icant conformational change (Fig. 2D), because the backbone RMSD
of the two structures is only 1.22 Å. There is only a small structural
difference in the RT-loop and n-Src loop regions, which are themost
ﬂexible regions of SH3 domains but engaged in the peptide binding.
The binding surface for PRR on a typical SH3 domain can be divided
into two areas, one is the PxxP binding pocket and the other is
located in between the RT-loop and n-Src loop [17]. The second
region is contributable to the ligand speciﬁcity of SH3 domain.
The signiﬁcant difference among the three SH3 domains of R85FL
is that SH3C contains more negatively charged residues (e.g. D20,
D21 and D39) on its surface (Fig. 2E). This negatively charged arealies in between the RT-loop and n-Src loop. In comparison, the cor-
responding surface of SH3A is roughly hydrophobic almost without
negative charge, while the surface of SH3B contains less negative
charge than that of SH3C. This charge difference might provide
molecular basis for the speciﬁcities of the SH3 domains binding
with partners. Actually, SH3B of R85FL binds with non-canonical
proline-rich motif [18], while SH3A of vinexin, a highly conserved
homolog of SH3A of R85FL, can also bind with a non-canonical pro-
line-rich motif [19].
3.3. Structural insights into the speciﬁc interaction between SH3C and
Atx7_PP2
Since SH3C has a negatively charged surface and Atx7_PP2 con-
tains a RRTRmotif with positive charges, the electric charges on the
surface may play important roles in mediating the electrostatic
Fig. 4. Complex structure of SH3C with Atx7_PP2. (A) Surface representation of SH3C showing the grooves for Atx7_PP2 binding. The positive charges, negative charges, and
the hydrophobic regions are shown in blue, red and gray, respectively. The R6, R7, T8 and R9 residues of Atx7_PP2 are illustrated in blue, while other residues are shown in
cyan. The hydrophobic interaction (left) and electrostatic interaction (right) are also highlighted in the graphs. (B) Detailed view of the interfaces for interaction of
R85FL_SH3C (ribbon) with Atx7_PP2 (stick). (C) As in (B), for interaction of R85FL_SH3B (ribbon) and the PRR peptide of paxillin (stick) (PDB ID, 2O9V).
Y.-J. Jiang et al. / FEBS Letters 587 (2013) 2905–2911 2909interaction between the two peptide chains, thus ion strength may
also inﬂuence the complex. Indeed, ITC experiments show that the
dissociation constant (KD) for SH3C bindingwith PP2 is signiﬁcantly
increased with an increase of salt concentration in the buffer
(Fig. 3A), suggesting that the electrostatic interactions are contrib-
utable to the formation of the SH3C–PP2 complex. NMR chemical-
shift perturbation exhibits that some residues like Y15, D21, D39,
W41 and Y59, experience signiﬁcant chemical-shift changes upon
PP2 binding (Fig. 3B). These residues are also contributable to con-
structing the xP groove and the speciﬁcity pocket of SH3 domain
[9,10,12]. Thus, both the proline-mediated hydrophobic interaction
and the arginine-conducted electrostatic interaction are crucial to
forming the complex between Atx7_PP2 and SH3C. More evidence
comes from the NOE signals between Atx7_PP2 and SH3C
(Fig. 3C). The b-methylene group of Pro56 of SH3C has only intra-
residue NOE signals in the free state, whereas some intermolecular
NOE signals appear in the complex, though they are still unsigned
due to 5 continuous prolines in Atx7_PP2. The intermolecular
NOE data from 13C ﬁltered/edited NOESY spectra are conﬁrmable
for this assumption (Fig. 3C, right panel). According to the chemi-
cal-shift pattern, these intermolecular NOE signals may come from
one of the proline residues of Atx7_PP2. We further characterized
the interaction between SH3C and Atx7_PP2 by PRE experiments.
The cross peaks of Y13, S14, Y15 and I16 of SH3C are signiﬁcantly
broadened when it binds with the N-terminally MTSL-labeled pep-
tide (Fig. 3D), indicating that the N-terminus of Atx7_PP2 is seated
around the xP groove of SH3C formed by Y13 and Y15. Meanwhile,
C-terminally labeled Atx7_PP2 causes large peak broadening of
D38, D39 and G40 (Fig. 3E), suggesting that the C-terminus ofAtx7_PP2 interacts with the acidic residues in the N-Src loop of
SH3C. The ITC experiments on various mutants of both Atx7_PP2
and SH3C further conﬁrm the viewpoint that the extended RRTR
motif of Atx7_PP2 and the key residues forming the xP groove
and speciﬁcity pocket of SH3C are important for the speciﬁc inter-
action (Table 1). The dramatic decrease of the binding afﬁnities in
the D21A and D39A mutants can account for the different recogni-
tion modes for polyproline peptides among the three SH3 domains
of R85FL (Fig. 1 and Fig. S2). Taken together, these results suggest
that both the xP groove and speciﬁcity pocket of SH3C are engaged
in the interaction with Atx7_PP2, while both the PPPPP and RRTR
motifs in Atx7_PP2 are also contributable to the speciﬁc interaction.
3.4. Structure model for the complex of SH3C and Atx7_PP2
Due to the relatively weak interaction and difﬁculty in NMR
assignment of the Atx7_PP2 peptide, we have not obtained enough
unambiguous intermolecular NOEs for direct computation of the
complex structure, so we generated a rational complex structure
by HADDOCK method [16], using the information from chemical
shift perturbation (Fig. 3B), intermolecular NOEs (Fig. 3C), PRE re-
straints (Fig. 3D and E) and binding afﬁnities of various mutants
(Table 1). With the experimental structure constraints as an input,
a major cluster of the initial complex structures were generated,
and a reﬁned structure was ﬁnally obtained (Fig. 4). In the struc-
ture model, the PPPPP motif is docked on the hydrophobic xP
groove of SH3C and the RRTR motif is directed to the negatively
charged speciﬁcity pocket (Fig. 4A). The prolines of Atx7_PP2 are
contacting with the xP groove of SH3C formed by Y13, Y15, W41,
Fig. 5. PolyQ expanded Atx7 (Atx7100Q) can sequester R85FL in cells. Normal
Atx710Q-GFP and polyQ expanded Atx7100Q-GFP were co-transfected with either
wild-type R85FL or its mutants in the SH3C moiety into HEK 293T cells, and
performed imaging with confocal ﬂuorescence microscopy. Nuclei were stained
with DAPI. I16A/Q18A is a double mutant of R85FL in the SH3C moiety, while D39A
is a point mutant of R85FL in the SH3C domain. DSH3C stands for the SH3C deletion
mutant of R85FL. Scalar bar = 10 lM.
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in the negatively charged speciﬁcity pocket formed by D21, E22,
D38 and D39. On the Atx7_PP2 side, R6 is pointed to the acidic
pocket of SH3C formed by D21 and E22, while both R7 and R9 lo-
cated at the pocket formed by D38 and D39. This is different from
the complex structure of SH3B of R85FL, in which the paxillin pep-
tide forms a type-II polyproline helix conformation [18]. The spec-
iﬁcity pocket of SH3B is comprised of Val, Asp, Asn and Ile residues,
corresponding to the residues of C37, D38, G40 and T54 in SH3C
(Fig. 2A), but there is no any charge involved in the interaction.
In essence, this structure model can explain the binding speciﬁcity
for Atx7_PP2 and the unique property of SH3C among the SH3 do-
mains of R85FL.
3.5. PolyQ expanded Atx7 (Atx7100Q) can sequester R85FL through
speciﬁc interaction with SH3C
Formation of inclusion bodies is the hallmark of polyQ ex-
panded neurodegenerative diseases, and the cellular inclusions
can sequester various kinds of proteins and probably lead themto dysfunction [7]. Using confocal microscopy, we investigated
the c0-localization of Atx7 with R85FL in cells. Normal Atx7
(Atx710Q) is a nucleus localized protein, while R85FL is distributed
mainly in cytosol (Fig. 5, 1st row). The polyQ expanded Atx7
(Atx7100Q) forms nuclear inclusion bodies, which can sequester
R85FL into the nucleus (Fig. 5, 2nd row). As a control, double muta-
tion (I16A/Q18A) in the SH3C moiety of R85FL, which does not al-
ter the interaction with Atx7_PP2, can also be sequestered into the
nucleus by Atx7100Q (Fig. 5, 3rd row). However, the D39Amutant in
the SH3C moiety of R85FL that signiﬁcantly reduces the binding
afﬁnity to the PP2 motif of Atx7 cannot be sequestered by Atx7100Q
(Fig. 5, 4th row). Moreover, deletion of SH3C in R85FL signiﬁcantly
abolishes sequestration of R85FL into the nucleus by Atx7100Q
(Fig. 5, 5th row). This observation indicates that the SH3C–PP2
interaction mediates the association of Atx7 and R85FL in cells.
The polyQ expanded Atx7 is prone to formation of inclusion bodies
and may signiﬁcantly alter the localization of R85FL from cytosol
to nucleus. This kind of abnormal interactions of the polyQ ex-
panded Atx7 with other partners may be implicated in the patho-
logical process of SCA7.4. Discussion
SH3 is a modular domain commonly found in all eukaryotic
genomes [10]. R85FL/ponsin is an adaptor protein that harbors
three SH3 domains in the C-terminus. Adaptor proteins are usually
composed of multiple modular domains for linking different parts
of enzymatic cascade or signal transduction pathway [20,21]. So
the three SH3 domains of R85FL must have evolved unique proper-
ties to accommodate different partners. Comparing the structures
of these three SH3 domains from R85FL reveals that the major dif-
ference for binding diverse PRR partners comes from the negatively
charged region between the RT loop and n-Src loop (Fig. 2E). This
structural difference among these three SH3 domains may provide
a possibility for R85FL to function both speciﬁcally and versatilely
in living cells.
Most SH3 domains recognize linear polyproline motif through
two pockets; one binds to the canonical PxxP core motif and the
other binds to the extended motif beyond the PxxP core [17]. Both
the canonical and non-canonical peptides associate with SH3 do-
mains through these two pockets. Although lots of SH3 domain
structures are available, it is still very hard to predict the interac-
tion partners of a SH3 domain, largely because of the high versatil-
ity of SH3 domains. Previous studies showed that the SH3C domain
of R85FL can interact with c-Cbl [22], 1-Afadin [23] and c-Abl [24].
The SH3C domain interacts with the PRR-containing partners with
a novel consensus motif of PxPPxRxSSL pattern at their binding
sites [25]. Besides the PxxP motif, the extended motif also plays
a crucial role in SH3 domain recognition [26–29]. However, these
SH3 domains bind with different polyproline peptides with the dis-
sociation constants around 1 lM, whereas the binding afﬁnity for
R85FL_SH3C with Atx7_PP2 is much weaker, till to an extent of
about 50 lM. The RxxK motif of Gab2 was reported to recognize
the SH3C domain of Grb2 [30]; both side-chains of Arg and Lys res-
idues point to the negatively charged region of the RT loop
(Fig. S4A). The interaction between Atx7 and R85FL is a little differ-
ent from that between Gab2 and Grb2. The negatively charged re-
gion of R85FL_SH3C includes both RT loop and n-Src loop, and each
residue of the RRTR motif in Atx7 contributes to the interaction
(Table 1). Another example is from the structural study of Mona/
Gads SH3C [27], which recognizes a PxxPxR/KxxK motif. The PxxP
motif binds to the two xP grooves of SH3C, while the R/KxxK motif
points to the negatively charged region of the RT loop (Fig. S4B). To
our knowledge, the interaction between R85FL_SH3C and
Atx7_PP2 represents a novel pattern. The diversity of the binding
Y.-J. Jiang et al. / FEBS Letters 587 (2013) 2905–2911 2911partners for an SH3 domain is expanded by combination of the
PxxP motif and an extended motif.
PolyQ disorders share several common pathological features,
including the nuclear accumulation and aggregation of the disease
proteins [7,31]. Numerous proteins can be sequestered by the nu-
clear inclusions, so that their functions must be abolished, which
can also be recognized as a pathogen for the polyQ diseases. Our
previous work has shown that polyQ expanded huntingtin (Htt)
can sequester Htt two-hybrid protein A (HYPA) through its PRR
interaction, and thus impairs the function of HYPA in pre-mRNA
splicing [32]. It is quite possible to be a similar case in R85FL.
The R85FL splicing variant ponsin/CAP regulates cytoskeleton
organization [33,34], insulin signal pathway [22,35,36], and recep-
tor-mediated endocytosis [37]. Actually, R85FL colocalizes with
Atx7 in the brain of SCA patients [13]. The sequestration of
R85FL by polyQ expanded Atx7 possibly leads to impairment of
the normal function of R85FL, which may partially contribute to
the pathology of the SCA7 disease.
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